Elevated IL-1β levels in the cerebrospinal fluid and peripheral blood are linked to AD and Parkinson’s disease (PD) (Blum-Degen et al., 1995; Ng et al., 2018; Fan et al., 2020). Here, IL1B is linked to Alzheimer disease.